AMRI certified for safe handling of potent APIs
AMRI's high potency research laboratories and GMP-manufacturing facilities in Rensselaer, New York have received SafeBridge certification for the safe handling of potent active pharmaceutical ingredients (APIs). The certificate applies to specific AMRI laboratories and manufacturing areas used for the research, development and manufacture of potent compounds.
AMRI's high potency research laboratories and GMP-manufacturing facilities in Rensselaer, New York have received SafeBridge certification for the safe handling of potent active pharmaceutical ingredients (APIs). The certificate applies to specific AMRI laboratories and manufacturing areas used for the research, development and manufacture of potent compounds.
The US drug discovery firm's SafeBridge-certified facilities include jacketed glass reactors, portable Hastelloy or glass-lined kettles, portable and fixed pressure filters/dryers, HPAPI isolators, as well as particle size reduction technology.
SafeBridge conducted a 60-element review of AMRI programmes, procedures and facilities used for the containment and control of potent APIs, including an on-site assessment of potent compound manufacturing and laboratory areas and equipment, training, toxicology and industrial hygiene practices.